Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - New York Times

Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - New York Times | marketing - Google News | January 05, 2016 at 03:06PM

Sanofi Ends Marketing Deal With Developer of Inhaled Insulin New York Times MannKind, the developer of the insulin, announced Tuesday that Sanofi, the big French drug company with the marketing rights, was terminating the agreement between the two companies. The move by Sanofi is not a surprise since the inhaled insulin ... and more »

January 05, 2016 at 03:06PM | marketing - Google News
Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - New York Times
marketing - Google News